title: Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.
abstract: 20-HETE (20-hydroxyeicosatetraenoic acid), a vasoconstrictor metabolite of arachidonic acid formed through the action of CYP4A (cytochrome P450-4A) in vascular smooth muscle cells, has been implicated in the development of hypertension and vascular dysfunction. There have been a number of reports in human subjects demonstrating an association between elevated urinary excretion of 20-HETE and hypertension, as well as increased 20-HETE production and vascular dysfunction. The Dahl SS (salt-sensitive) rat is a genetic model of salt-sensitive hypertension that exhibits vascular dysfunction, even when maintained on a normal-salt diet and before the development of hypertension. This mini-review highlights our current research on the role of CYP4A and 20-HETE in the vascular dysfunction of the Dahl SS rat. In our studies, the SS rat is compared with the consomic SS-5BN rat, having chromosome 5 from the salt-resistant Brown Norway rat (carrying all CYP4A genes) introgressed on to the SS genetic background. Our laboratory has demonstrated restoration of normal vascular function in the SS rat with inhibition of the CYP4A/20-HETE pathway, suggesting a direct role for this pathway in the vascular dysfunction in this animal model. Our studies have also shown that the SS rat has an up-regulated CYP4A/20-HETE pathway within their cerebral vasculature compared with the SS-5BN consomic rat, which causes endothelial dysfunction through the production of ROS (reactive oxygen species). Our data shows that ROS influences the expression of the CYP4A/20-HETE pathway in the SS rat in a feed-forward mechanism whereby elevated ROS stimulates production of 20-HETE. The presence of this vicious cycle offers a possible explanation for the spiralling effects of elevated 20-HETE on the development of vascular dysfunction in this animal model.
authors: Department of Physiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. kathleen.lukaszewicz@marquette.edu
authors: Kathleen M
authors: KM
authors: Lukaszewicz
authors: Julian H
authors: JH
authors: Lombard
mesh_terms: D000818:Animals; D001794:Blood Pressure; D002536:Cerebral Arteries / Q000201:enzymology / Q000503:physiopathology; D042926:Cytochrome P-450 CYP4A / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism*; D006973:Hypertension / Q000139:chemically induced / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000201:enzymology* / Q000503:physiopathology; D051381:Rats; D011914:Rats, Inbred BN; D020303:Rats, Inbred Dahl; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction; D017673:Sodium Chloride, Dietary; D015854:Up-Regulation; D014661:Vasoconstriction
chemical_list: D006893:Hydroxyeicosatetraenoic Acids; D017382:Reactive Oxygen Species; D017673:Sodium Chloride, Dietary; C055987:20-hydroxy-5,8,11,14-eicosatetraenoic acid; D042926:Cytochrome P-450 CYP4A